Showing results (101-110 of 207) with videos related to
Sort By:
Pageof 21
Frontiers in Oncology|May 12, 2020
IGF-1 Interacted With Obesity in Prognosis Prediction in HER2-Positive Breast Cancer PatientsYiwei Tong, Jiayi Wu, Ou Huang, et al.BMC Cancer|July 14, 2021
Clinical characteristics and disease outcomes in ER+ breast cancer: a comparison between HER2+ patients treated with trastuzumab and HER2- patientsShuai Li, Jiayi Wu, Ou Huang, et al.Breast Cancer Research and Treatment|April 3, 2019
4-Hydroxytamoxifen enhances sensitivity of estrogen receptor α-positive breast cancer to docetaxel in an estrogen and ZNF423 SNP-dependent fashionGen Wang, Sisi Qin, Jacqueline Zayas, et al.Journal of Translational Medicine|February 17, 2021
A nomogram to predict the high-risk RS in HR+/HER2-breast cancer patients older than 50 years of ageJing Yu, Jiayi Wu, Ou Huang, et al.Journal of Cancer|October 30, 2020
Early response and pathological complete remission in Breast Cancer with different molecular subtypes: a retrospective single center analysisJin Hong, Jiayi Wu, Ou Huang, et al.The International Journal of Biochemistry & Cell Biology|December 9, 2015
Niclosamide inhibits epithelial-mesenchymal transition and tumor growth in lapatinib-resistant human epidermal growth factor receptor 2-positive breast cancerJunjun Liu, Xiaosong Chen, Toby Ward, et al.Discover Oncology|October 27, 2025
Microenvironmental regulation and remodeling of breast cancer angiogenesis: from basic mechanisms to clinical therapeutic implicationsZiling Zhou, Hanyi Zhong, Han Wang, et al.Annals of Translational Medicine|April 12, 2021
A novel metabolic gene signature-based nomogram to predict overall survival in breast cancerXi Sun, Zhi-Rui Zhou, Yan Fang, et al.Journal of Clinical Medicine|September 9, 2022
A Novel Nomogram for Predicting Prognosis and Tailoring Local Therapy Decision for Ductal Carcinoma In Situ after Breast Conserving SurgeryFeifei Xu, Lu Cao, Cheng Xu, et al.Amino Acids|March 7, 2015
Targeting rho guanine nucleotide exchange factor ARHGEF5/TIM with auto-inhibitory peptides in human breast cancerOu Huang, Dandan Wu, Feiyan Xie, et al.Pageof 21